NCT00187109View on ClinicalTrials.gov

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Germ Cell TumorsHepatic CancerNeuroblastomaOsteosarcomaRhabdomyosarcoma
Interventions
DRUG

Recombinant Human Thrombopoietin

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00187109 - Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | Biotech Hunter | Biotech Hunter